Clinical Trials for: silodosin
Use of Silodosin to Treat Moderate to Severe Abacterial Chronic Prostatitis/Chronic Pelvic Pain Syndrome.
Status: Completed Condition: Abacterial Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Effectiveness and Safety of Silodosin in the Treatment of Benign Prostatic Hyperplasia
Status: Active, not recruiting Condition: Benign Prostatic Hyperplasia
Safety and Efficacy of QD Versus BID Silodosin With Lower Urinary Tract Symptoms Suggestive of BPH
Status: Completed Condition: Benign Prostatic Hypertrophy
Study of a α1A Adrenoceptor Selective Antagonist Silodosin to Treat Severe Benign Prostatic Hyperplasia(BPH)
Status: Completed Condition: Benign Prostatic Hyperplasia
Efficacy and Safety of Silodosin on Nocturia for Patients With Benign Prostatic Hyperplasia
Status: Recruiting Condition: Nocturia; Benign Prostatic Hyperplasia
Efficacy and Safety of Silodosin on Voiding Dysfunction Associated With Neurogenic Bladder
Status: Completed Condition: Neurogenic Bladder; Voiding Dysfunction
A Study of Silodosin 8 mg Daily for the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia
Status: Completed Condition: Nocturia; Prostatic Hyperplasia
A Dose-finding Study of Silodosin in Patients With Urinary Calculi
Status: Completed Condition: Urinary Calculus
Differential Effect of Silodosin Versus Tamsulosin on Stone Clearance After Extra-corporeal Shock Wave Lithotripsy
Status: Not yet recruiting Condition: Kidney Stones
Efficacy and Safety of Silodosin in the Treatment of Natural Expulsion in Patients With Ureteral Stones
Status: Completed Condition: Ureteral Stone
Courtesy of ClinicalTrials.org
See more clinical trials for this drug
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||Type||RLD||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Patented / Exclusive Use|
|CAPSULE;ORAL||022206||Oct 8, 2008||RX||Yes||5,387,603||<disabled>||Y||Y|
|CAPSULE;ORAL||022206||Oct 8, 2008||RX||Yes||<disabled>||NEW CHEMICAL ENTITY|
|CAPSULE;ORAL||022206||Oct 8, 2008||RX||No||5,387,603||<disabled>||Y||Y|
|CAPSULE;ORAL||022206||Oct 8, 2008||RX||No||<disabled>||NEW CHEMICAL ENTITY|
|This preview shows a limited data set|
Complete access is available with a Subscription
Export unavailable in trial.
Subscribe for complete access.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639